[Clinical study of tolerance and effectiveness of a F(ab')(2) polyvalent antienom for African snake bites in Kindia, Guinea].

@article{Balde2012ClinicalSO,
  title={[Clinical study of tolerance and effectiveness of a F(ab')(2) polyvalent antienom for African snake bites in Kindia, Guinea].},
  author={Mamadou Cellou Balde and Jean-Philippe Chippaux and Mamadou Y Boiro and Roberto Pablo Stock and Achille Massougbodji},
  journal={Bulletin de la Societe de pathologie exotique},
  year={2012},
  volume={105 3},
  pages={157-61}
}
An open, pragmatic, phase IV clinical trial was undertaken to measure tolerance and assess the effectiveness of Antivipmyn® Africa, antivenom composed of lyophilized F(ab')(2) fragments of immunoglobulin G in field conditions. The study was conducted at the Institut Pasteur of Guinea (IPG) from August 2009 to February 2010. Two hundred twenty-eight victims… CONTINUE READING